Delivery Order SPE2DR25D2009-SPE2DR26FJ5T4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $20,765.70 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,103.78 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,456.52 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90 count) on January 14, 2026, with completion scheduled for January 15, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up...
- The Defense Logistics Agency awarded a delivery order valued at $35,688.67 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) with a firm fixed-price structure. This competitively awarded, non-set-aside order was executed on January 16, 2026, with an ultimate completion date of January 20, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,720.85 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside delivery order is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly operating as AmerisourceBergen), is...
- The Defense Logistics Agency awarded a delivery order valued at $25,475.56 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $10.77K delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) with an ultimate completion date of January 22, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,529.94 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $28,817.72 to Amerisourcebergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) with a firm fixed-price structure. The contract, awarded on January 23, 2026, is scheduled for ultimate completion by January 26, 2026, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $3,710.89 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Gemtesa 75 mg tablets (90-count units). This non-set-aside, competitively awarded contract carries a firm fixed-price structure with an ultimate completion date of January 9, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ5T4Delivery Order
The Defense Logistics Agency awarded a $32.4K delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 27, 2026, for the supply of Gemtesa 75 mg tablets in quantities of 90 units. This is a firm fixed-price, non-set-aside contract with a completion date of January 28, 2026, performed at the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's role within this vehicle encompasses delivering specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific task order represents one of numerous competitive awards under the broader pharmaceutical supply agreement, demonstrating the contractor's ongoing capability to meet federal healthcare supply requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.4k | 1/26/26 |